Screener
Revolution Medicines, Inc. RVMD Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s interest expense?
- Revolution Medicines, Inc. (RVMD) reported interest expense of $12.2M in Q1 2026.
- What is the long-term trend for Revolution Medicines, Inc.'s interest expense?
- Over 3 years (2021 to 2025), Revolution Medicines, Inc.'s interest expense has grown at a 1164.0% compound annual growth rate (CAGR), from $12K to $24.23M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Revolution Medicines, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude